1. Home
  2. FTFT vs BMRA Comparison

FTFT vs BMRA Comparison

Compare FTFT & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Future FinTech Group Inc.

FTFT

Future FinTech Group Inc.

N/A

Current Price

$1.39

Market Cap

7.5M

ML Signal

N/A

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$1.97

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTFT
BMRA
Founded
N/A
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
6.3M
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
FTFT
BMRA
Price
$1.39
$1.97
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.6K
13.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
31.14
N/A
EPS
N/A
N/A
Revenue
$2,158,125.00
$5,311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.40
52 Week High
$4.03
$4.60

Technical Indicators

Market Signals
Indicator
FTFT
BMRA
Relative Strength Index (RSI) 44.35 39.33
Support Level $1.29 $1.87
Resistance Level $1.60 $2.40
Average True Range (ATR) 0.11 0.14
MACD -0.01 0.00
Stochastic Oscillator 28.79 22.99

Price Performance

Historical Comparison
FTFT
BMRA

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: